Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?

NCT ID NCT07763795

Symptom relief Sponsor: Superior University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether blood flow restriction (BFR) training—exercising with a cuff that partially limits blood flow—can improve blood sugar control, nerve function, pain, and quality of life in people with type 2 diabetes and peripheral neuropathy. Participants will be randomly assigned to either BFR with low-resistance exercises or the same exercises without BFR. The study aims to see if this innovative training method can help manage a common and debilitating complication of diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood flow restriction (BFR) training combined with low-resistance, high-repetition exercises
What this could lead to
If effective, this approach could offer a new, drug-free way to improve blood sugar control, nerve function, and quality of life for people with diabetic neuropathy.
What could go wrong
This is a small, early-stage trial, and results may not apply to everyone. The training involves restricting blood flow, which carries risks like blood clots or injury, especially in people with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * type 2 diabetes (≥5 years) patients diagnosed * random blood glucose ≥ 11.1mmol/L; * fasting blood glucose ≥ 7.0 mmol/L * Haemoglobin A1c 6.5%-9.5%. 2) Can walk independently, no severe joint limitations * Can safely perform resistance training * Stable diabetic \& neuropathy meds for 3+ months Exclusion Criteria: * suffers frequent hypoglycaemia, * severe diabetes complications * Diagnosed cases of neuromuscular disorders * history of stroke/DVT

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic neuropathy peripheral are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetic neuropathy diabetic polyneuropathy type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic neuropathy peripheral

Contacts and locations

Locations

  • Sahiwal Diabetes and Foor care Clinic

    Sahiwal, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.